Marker | Admission | Hours after admission | ||||||
---|---|---|---|---|---|---|---|---|
6 | 12 | 24 | ||||||
OR | P value | OR | P value | OR | P value | OR | P value | |
Unfavorable 6-month GOSE | ||||||||
 IL-1β | 0.84 | 0.489 | 1.84* | 0.002 | 1.65* | 0.009 | 0.91 | 0.673 |
 IL-10 | 1.18 | 0.376 | 1.76* | 0.005 | 1.57* | 0.019 | 1.48* | 0.034 |
 TNF-α | 1.49* | 0.024 | 1.61* | 0.008 | 1.50* | 0.021 | 1.30 | 0.138 |
 IL-8 | 1.66* | 0.007 | 1.48* | 0.030 | 1.44* | 0.036 | 1.33 | 0.104 |
 MCP-1 | 1.42 | 0.052 | 1.09 | 0.603 | 1.24 | 0.213 | 1.39 | 0.067 |
 MDC | 1.10 | 0.586 | 0.90 | 0.515 | 1.45 | 0.037* | 0.85 | 0.363 |
Mortality | Â | Â | Â | Â | Â | Â | Â | Â |
 IL-1β | 1.02 | 0.935 | 1.06 | 0.825 | 1.85* | 0.038 | 1.15 | 0.598 |
 IL-10 | 1.19 | 0.417 | 2.82* | <0.001 | 2.09* | 0.003 | 2.20* | 0.003* |
 TNF-α | 1.58* | 0.027 | 1.77* | 0.007 | 1.58* | 0.033 | 1.19 | 0.395 |
 IL-8 | 1.31 | 0.168 | 1.89* | 0.005 | 1.84 | 0.010* | 1.37 | 0.176 |
 IP-10 | 3.11* | <0.001 | 2.06* | 0.002 | 1.59* | 0.030 | 1.19 | 0.400 |
 MCP-1 | 1.26 | 0.230 | 1.46 | 0.069 | 1.57* | 0.035 | 0.91 | 0.674 |
 MCP-4 | 1.43 | 0.090 | 1.49 | 0.065 | 0.99 | 0.964 | 0.57* | 0.023 |
 MDC | 1.03 | 0.864 | 0.91 | 0.620 | 1.14 | 0.529 | 0.71 | 0.114 |
 MIP-1β | 1.13 | 0.544 | 1.27 | 0.243 | 1.29 | 0.221 | 0.89 | 0.592 |
 TARC | 0.95 | 0.801 | 1.00 | 0.991 | 0.77 | 0.231 | 0.56* | 0.015 |
 Eotaxin | 1.90* | 0.005 | 1.90* | 0.007 | 1.33 | 0.208 | 0.79 | 0.304 |